
Results
9
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
9 companies
STIF Société anonyme
Market Cap: €252.3m
Manufactures and sells components for the handling of bulk products in France.
ALSTI
€49.12
7D
13.4%
1Y
36.6%
DBV Technologies
Market Cap: €974.9m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€3.50
7D
-3.6%
1Y
190.5%
OSE Immunotherapeutics
Market Cap: €69.9m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€3.12
7D
-5.2%
1Y
-42.6%
SPIE
Market Cap: €8.1b
Provides multi-technical services in the areas of energy and communications in France, Germany, the Netherlands, and internationally.
SPIE
€47.86
7D
8.7%
1Y
25.2%
Antin Infrastructure Partners SAS
Market Cap: €1.9b
A private equity firm specializing in infrastructure investments.
ANTIN
€10.44
7D
-2.1%
1Y
11.1%
Vusion
Market Cap: €1.8b
Engages in the provision of digitalization solutions for commerce in Europe, Asia, and North America.
VU
€107.40
7D
-1.2%
1Y
-41.3%
Sword Group
Market Cap: €296.8m
Provides IT and software solutions.
SWP
€31.40
7D
0.2%
1Y
0.6%
Figeac Aero Société Anonyme
Market Cap: €421.3m
Manufactures, supplies, and sells equipment and sub-assemblers for aeronautics sector in France.
FGA
€9.55
7D
-1.7%
1Y
22.4%
Eurazeo
Market Cap: €2.7b
A private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments.
RF
€43.46
7D
5.0%
1Y
-22.0%